Double remission of simultaneously occurring secondary AML and CLL by venetoclax monotherapy-Reference-Cited by-同舟云学术

Double remission of simultaneously occurring secondary AML and CLL by venetoclax monotherapy

Published:2019-03-08 Issue:6 Volume:58 Page:888-890
ISSN:0284-186X
Container-title:Acta Oncologica
language:en
Short-container-title:Acta Oncologica

Author:

Niscola Pasquale¹^ORCID,Noguera Nélida Inés²,Catalano Gianfranco¹,Cupelli Luca¹,Fratoni Stefano³,Giovannini Marco¹,Mazzone Carla¹,Neri Benedetta¹,Scaramucci Laura¹,Trawinska Malgorzata Monika¹,de Fabritiis Paolo¹,Abruzzese Elisabetta¹

Affiliation:

1. Hematology Unit, Saint’ Eugenio Hospital, Tor Vergata University of Rome, Rome, Italy;

2. Neuro Oncohematology Unit, Santa Lucia Foundation and Department of Biomedicine and Prevention, Tor Vergata University of Rome, Rome, Italy;

3. Department of Pathology, Saint’ Eugenio Hospital, Rome, Italy

Publisher

Informa UK Limited

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/0284186X.2019.1585943

Reference22 articles.

1. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia

2. How I treat the blast phase of Philadelphia chromosome–negative myeloproliferative neoplasms

3. Concomitant transformation of monoclonal gammopathy of undetermined significance to multiple myeloma and of essential thrombocythemia to acute biphenotypic leukemia 37 years after initial diagnosis

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of venetoclax and rituximab in the treatment of concurrent acute myeloid leukemia and untreated chronic lymphocytic leukemia: A case report and literature review;Oncology Letters;2024-06-25

2. Double remission of chronic lymphocytic leukemia and secondary acute myeloid leukemia after venetoclax monotherapy;Medicine;2021-02-12

3. Current clinical strategies and emergent treatment landscapes in leukemic transformation of Philadelphia-negative myeloproliferative neoplasms;Expert Review of Hematology;2020-12-01